Sort
39,280 grants matching “leukemia”
Expression profiling of renal cell carcinoma utilizing tissue from CALGB 90206
$343,754Hyung L Kim · Cedars-Sinai Medical Center · R01 · FY2012 · CA
Ikaros-based epigenetic regulation of T cell leukemogenesis
$343,736Katia Georgopoulos · Massachusetts General Hospital · R01 · FY2012 · CA
A Thymus - Bone Marrow Feedback Loop for Prothymocytes
$343,715Irving Goldschneider · University Of Connecticut Sch Of Med/Dnt · R01 · FY2007 · AI
Terminal Transferase and Lymphocyte Development
$343,715John Franklin Kearney · University Of Alabama At Birmingham · R01 · FY2007 · AI
CSF2 receptor mediated actions in t(8;21) leukemia
$343,706Dong-Er Zhang · University Of California, San Diego · R01 · FY2017 · CA
Endocrine disrupter modulation of SXR in development and lymphomagenesis
$343,685Bruce Blumberg · University Of California-Irvine · R01 · FY2014 · ES
FLT3 as a Target for Drug Discovery to Treat Leukemia
$343,685Johns Hopkins University · U01 · FY2003 · CA
Th1/Th17 Cell Differentiation in GVHD and GVL
$343,632Xue-Zhong Yu · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2010 · CA
Bone Marrow Transplantation for Hematologic Malignancies using Novel Radioimmunot
$343,617Oliver W. Press · Fred Hutchinson Cancer Research Center · R01 · FY2014 · CA
Core A - Clinical Database.
$343,570Peter Westervelt · Washington University · P01 · FY2021 · CA
Deciphering the molecular mechanisms of TNT formation and function using a multi-omic approach
$343,544Karine Gousset · California State University Fresno · SC1 · FY2022 · GM
Targeting cell trafficking as a new therapeutic modality for Multiple Myeloma
$343,498Irene M. Ghobrial · Dana-Farber Cancer Inst · R01 · FY2011 · CA
Identification of Loci Modifying Atm Lymphomagenesis
$343,463Michael M. Weil · Colorado State University · R01 · FY2017 · CA
The role of microRNAs in leukemic initiation and maintenance
$343,413Jun Lu · Yale University · R01 · FY2011 · CA
Analysis of higher order chromatin structures in normal and cancer epigenomes
$343,413Tae Hoon Kim · Yale University · R01 · FY2010 · CA
Targeting Cancer Stem Cells
$343,404Richard J Jones · Johns Hopkins University · P01 · FY2016 · CA
Targeting Cancer Stem Cells
$343,404Richard J Jones · Johns Hopkins University · P01 · FY2015 · CA
Targeting Cancer Stem Cells
$343,404Richard J Jones · Johns Hopkins University · P01 · FY2012 · CA
Targeting Endoplasmic Reticulum Stress Sensor IRE1 to Enhance Chemotherapy Sensitivity in MYC-driven breast cancer
$343,397Xi Chen · Baylor College Of Medicine · P50 · FY2020 · CA
Tyrosine kinase inhibitors for the treatment of childhood AML
$343,388Sharyn D Baker · Ohio State University · R01 · FY2017 · CA
Tyrosine kinase inhibitors for the treatment of childhood AML
$343,388Sharyn D Baker · Ohio State University · R01 · FY2018 · CA
Tyrosine kinase inhibitors for the treatment of childhood AML
$343,388Sharyn D Baker · Ohio State University · R01 · FY2016 · CA
The reduction of NLRX1 and its role in pulmonary aging
$343,375Min-Jong Kang · Yale University · R01 · FY2019 · AG
The reduction of NLRX1 and its role in pulmonary aging
$343,375Min-Jong Kang · Yale University · R01 · FY2017 · AG
The reduction of NLRX1 and its role in pulmonary aging
$343,375Min-Jong Kang · Yale University · R01 · FY2016 · AG